Here are three to note:
Laval, Canada-based Valeant Pharmaceuticals CEO Joe Papa said the company is focusing on increasing its revenue and paying down debt at the New York City-based RBC investor conference.
Caesarea, Israel-based LifeBond is enrolling patients in the United States and Western Europe for its LifeSeal Surgical Sealant’s IDE clinical trial. The gastrointestinal-facing sealant provides reinforcement and minimizes staple-line leakage.
Little Falls, N.J.-based Cantel Medical Corp. agreed to purchase Australia-based distributor CR Kennedy & Co.’s endoscopy business. The distributor’s assets consist of Cantel’s Medivators-branded products, which offer infection prevention solutions for endoscope reprocessing and endoscopy procedures.
More articles on gastroenterology/endoscopy:
Philips’ ElastQ receives FDA 510(k) clearance: 4 key notes
GI leader to know: Dr. Asif Qadri of Athens Digestive Healthcare Associates
Iowa hospital settles botched colonoscopy for $500k: 3 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
